Drug intelligence / Profile preview

polyethylene glycol 400 + propylene glycol (Alcon Inc.)

Development stage
Unknown
Lead developer
Alcon
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Systane Ultra PF is a preservative-free lubricant eye drop developed by Alcon for the management of dry eye disease (DED) and ocular discomfort associated with contact lens wear. The formulation contains two active demulcents, polyethylene glycol 400 (0.4%) and propylene glycol (0.3%), which work synergistically to supplement the aqueous layer of the tear film and protect the corneal epithelium from dehydration. As a preservative-free (PF) product, it is specifically indicated for patients with sensitive eyes or those who require frequent daily dosing, as it eliminates the risk of ocular surface toxicity often associated with preservatives like benzalkonium chloride. Clinical studies, including Phase IV post-market follow-up trials, have demonstrated that Systane Ultra PF effectively improves clinical parameters such as tear break-up time (TBUT), goblet cell density, and Ocular Surface Disease Index (OSDI) scores, providing symptom relief comparable to preserved formulations while maintaining a superior safety profile for long-term use.

Brand names
Systane Ultra PFSystane Ultra Preservative Free Lubricant Eye Drops
Other names
PEG/PG-PFpolyethylene glycol 400 0.4% and propylene glycol 0.3% preservative-free

Beyond the preview

Go deeper on polyethylene glycol 400 + propylene glycol (Alcon Inc.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyethylene glycol 400 + propylene glycol (Alcon Inc.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call